Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

SHAWN GAURAV KWATRA

Allopathic & Osteopathic Physicians Dermatology

NPI
1205191400
CMS profile
596654
Location
BALTIMORE, MD

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$408,995.52

151 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

By paying entity

PY2023 · entire year · sorted by reported total

Page 4 of 4; records 151–151 of 151 matching records. This page contains 1 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

SHAWN GAURAV KWATRA

NPI 1205191400 · CMS profile ID 596654

Allopathic & Osteopathic Physicians / Dermatology

BALTIMORE, MD

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 4 of 4; records 151–151 of 151 matching records. This page contains 1 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1205191400?year=2023&recipient=provider&page=4#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
SHAWN GAURAV KWATRA, NPI 1205191400, CMS profile ID 596654. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 4; records 151–151 of 151 matching records. This page contains 1 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1205191400?year=2023&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). SHAWN GAURAV KWATRA, NPI 1205191400, CMS profile ID 596654. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 4; records 151–151 of 151 matching records. This page contains 1 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1205191400?year=2023&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
SHAWN GAURAV KWATRA, NPI 1205191400, CMS profile ID 596654, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 4 of 4; records 151–151 of 151 matching records. This page contains 1 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1205191400?year=2023&recipient=provider&page=4#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

151 matching records · $408,995.52 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 151 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 151–151 of 151.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Regeneron Healthcare Solutions, Inc. $119.4701/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999262125 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $16,099.06 26
PY2020 $9,124.84 14
PY2021 $37,740.74 21
PY2022 $261,790.69 90
PY2023 $408,995.52 151
PY2024 $246,939.65 127
PY2025 $105,484.83 73

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Recipient $1,000.00 2
PY2025 Principal investigator $233,316.87 17
PY2024 Recipient $9,539.33 2
PY2024 Principal investigator $62,317.16 16
PY2023 Recipient $19,253.23 37
PY2023 Principal investigator $155,911.18 136
PY2022 Recipient $14,801.37 21
PY2022 Principal investigator $65,370.93 55
PY2021 Recipient $9,374.48 9
PY2021 Principal investigator $620,160.21 19
PY2020 Recipient $12,890.00 12
PY2020 Principal investigator $141,716.16 4

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

19 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Incyte Corporation $2,322.90 12/19/2025 Non-covered Recipient Entity
UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE
A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN2) No dispute reported 06/30/2026 1240608293
Principal investigator 1 Incyte Corporation $4,073.80 12/04/2025 Non-covered Recipient Entity
UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE
A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN2) No dispute reported 06/30/2026 1240608289
Principal investigator 1 Incyte Corporation $2,322.90 11/25/2025 Non-covered Recipient Entity
UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE
A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN2) No dispute reported 06/30/2026 1240608285
Principal investigator 1 Incyte Corporation $2,795.40 11/20/2025 Non-covered Recipient Entity
UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE
A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN2) No dispute reported 06/30/2026 1240608279
Principal investigator 1 Incyte Corporation $2,916.90 11/07/2025 Non-covered Recipient Entity
UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE
A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN2) No dispute reported 06/30/2026 1240608282
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $37,304.65 11/05/2025 Non-covered Recipient Entity
UNIVERSITY OF MARYLAND BALTIMORE
Real-world utilization of dupilumab for atopic dermatitis No dispute reported 06/30/2026 1184257205
Principal investigator 1 Incyte Corporation $7,840.80 10/29/2025 Non-covered Recipient Entity
UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE
A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN2) No dispute reported 06/30/2026 1240608270
Principal investigator 1 Incyte Corporation $2,795.40 10/09/2025 Non-covered Recipient Entity
UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE
A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN2) No dispute reported 06/30/2026 1240608274
Principal investigator 1 Incyte Corporation $594.00 09/23/2025 Non-covered Recipient Entity
UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE
A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN2) No dispute reported 06/30/2026 1240608266
Recipient GENZYME CORPORATION $500.00 09/17/2025 Covered Recipient Physician A Randomized, Double Blind, Placebo-controlled, Multi-center, Parallel Group Study to Evaluate the Efficacy and Safety of Dupilumab in Patients With Prurigo Nodularis Who Are Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable No dispute reported 06/30/2026 1226127354
Recipient GENZYME CORPORATION $500.00 09/17/2025 Covered Recipient Physician A Randomized, Double Blind, Placebo-controlled, Multi-center, Parallel Group Study to Evaluate the Efficacy and Safety of Dupilumab in Patients With Prurigo Nodularis Who Are Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable No dispute reported 06/30/2026 1226127358
Principal investigator 1 Incyte Corporation $17,398.80 09/12/2025 Non-covered Recipient Entity
UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE
A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN2) No dispute reported 06/30/2026 1240608262
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $45,498.85 08/06/2025 Non-covered Recipient Entity
UNIVERSITY OF MARYLAND BALTIMORE
Real-world utilization of dupilumab for atopic dermatitis No dispute reported 06/30/2026 1184223606
Principal investigator 1 SANOFI US SERVICES INC. $2,568.00 08/04/2025 Non-covered Recipient Entity
Johns Hopkins University
Master Protocol of Two Randomized, Double Blind, Placebo-controlled, Multi-center, Parallel Group Studies to Evaluate the Efficacy and Safety of Dupilumab in Adult Patients With Chronic Pruritus of Unknown Origin (CPUO) No dispute reported 06/30/2026 1226081194
Principal investigator 1 Incyte Corporation $4,200.00 06/05/2025 Non-covered Recipient Entity
UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE
A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN2) No dispute reported 06/30/2026 1240608250
Principal investigator 1 Incyte Corporation $22,200.00 06/05/2025 Non-covered Recipient Entity
UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE
A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN2) No dispute reported 06/30/2026 1240608252
Principal investigator 1 Incyte Corporation $10,605.00 06/05/2025 Non-covered Recipient Entity
UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE
A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN2) No dispute reported 06/30/2026 1240608255
Principal investigator 1 Incyte Corporation $2,335.71 01/28/2025 Non-covered Recipient Entity
UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE
TRuE AD1 - An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic Dermatitis No dispute reported 06/30/2026 1240608258
Principal investigator 1 PFIZER INC. $65,543.76 01/27/2025 Non-covered Recipient Entity
THE JOHNS HOPKINS UNIVERSITY
EFFICACY OF ABROCITINIB FOR PNCPUO No dispute reported 06/30/2026 1228801004